Clinical trial
Medical Expulsive Therapy for Ureter Stone Using Naftopidil
NCT01952314 · Seoul National University Hospital, Other · Completed
Key facts
| NCT number | NCT01952314 |
|---|---|
| Title | Medical Expulsive Therapy for Ureter Stone Using Naftopidil |
| Official title | Medical Expulsive Therapy for Ureter Stone Using Naftopidil: Multicenter, Randomized, Double-blind, Placebo Controlled Study |
| Lead sponsor | Seoul National University Hospital, Other |
| Collaborators | Dong-A ST Co., Ltd. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ureter Stones |
| Intervention type | Drug |
| Interventions | Naftopidil 75mg, Placebo for Naftopidil, Standard treatment |
| Enrollment | 150 |
| Start date | May 1, 2014 |
| Primary completion | Aug 1, 2015 |
| Completion | Aug 1, 2015 |
| First posted | Sep 27, 2013 |
| Last update posted | Dec 10, 2015 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: